GA-68 dotatate (netspot)
Ended Awarded
- Contract number
- 36C24826N0026
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $171,860
Award facts
- Contract value 100% obligated
- $171,859.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- East Hanover, NJ 07936, USA
Award details come from SAM.gov/FPDS.
About this award
Novartis Pharmaceuticals Corporation, a foreign-owned pharmaceutical manufacturer headquartered in East Hanover, New Jersey, was awarded a firm fixed-price delivery order valued at $171,859.50 for GA-68 DOTATATE (NETSPOT) by the Department of Veterans Affairs' Veterans Integrated Service Network 8. The award, announced on October 1, 2025, with a completion date of September 30, 2026, represents a direct award with no small business set-aside. This delivery order is placed against Novartis' existing Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), enabling the VA to procure this specialized radiopharmaceutical for nuclear medicine applications, particularly in cancer imaging and diagnosis.
NETSPOT is a diagnostic radiopharmaceutical used in positron emission tomography imaging to support detection and staging of neuroendocrine tumors and other malignancies. This procurement supports the VA's mission to provide innovative medical treatments to veterans through its integrated service networks. Novartis has established itself as a key supplier to federal healthcare systems, with a substantial Indefinite Delivery Contract valued at approximately $26.1 million from the Defense Health Agency and a Blanket Purchase Agreement worth $7.48 million from VA's Integrated Service Network 10, demonstrating the company's significant role in supplying advanced cancer therapies and radiopharmaceuticals across multiple federal agencies.
Quick answers
Who was awarded contract 36C24826N0026?
36C24826N0026 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 8 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C24826N0026 worth?
The government has obligated $171,860 on 36C24826N0026.
Is contract 36C24826N0026 an order under another contract?
Yes. 36C24826N0026 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24826N0026 competed?
The extent of competition for 36C24826N0026 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award